CAP TODAY Webinar
Wednesday, May 24, 2023, 1:00 PM–2:00 PM ET
Register Now
Lauren Ritterhouse, MD, PhD
Associate Director, Center for Integrated Diagnostics
Massachusetts General Hospital
Assistant Professor, Pathology, Harvard Medical School
Ibiayi Dagogo-Jack, MD
Thoracis Oncologist, Massachusetts General Hospital
Assistant Professor of Medicine, Harvard Medical School
Why should you register now for this webinar?
Hear about experience from the Massachusetts General Hospital (MGH). Their Center for Integrated Diagnostics (CID) has consolidated legacy single gene testing system in to one workflow based on fast and automated next generation sequencing (NGS)—a rapid lung molecular testing program. This workflow allows for a turn around time (TAT) of 36-72 hours and provides clinicians with a consolidated biomarker report, whilst significantly reducing complexity, hands on time and costs in the lab.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenters
Lauren Ritterhouse, MD, PhD
Associate Director, Center for Integrated Diagnostics
Massachusetts General Hospital
Assistant Professor, Pathology, Harvard Medical School
Ibiayi Dagogo-Jack, MD
Thoracis Oncologist, Massachusetts General Hospital
Assistant Professor of Medicine, Harvard Medical School
What will this webinar empower you to do?
- Learn from the experiences of a leading cancer center in consolidation NSCLC biomarker testing in to Rapid Lung NGS program
- Understand the positive implications for oncologists and patients with cancer from the oncologist point of view
- Understand how the new consolidated workflow saves time and resources
CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special educational grant from Thermo Fisher Scientific.